Canine Aβ42 antibody and antigen (recombinant protein)
Diagnostic anti-Canine Aβ42 antibodies pairs and antigen for animal health (animal Dog/Canine Alzheimer Disease(AD)) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Companion Animal disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-CAN-AB42-Ag01 | Canine Aβ42 | $3090.00 |
GMP-CAN-AB42-Ab01 | Anti-Canine Aβ42 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-AB42-Ab02 | Anti-Canine Aβ42 mouse monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-AB42-Ab03 | Anti-Canine Aβ42 human monoclonal antibody (mAb) | $3090.00 |
GMP-CAN-AB42-Ab04 | Anti-Canine Aβ42 human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-CAN-AB42-Ag01 |
Product Name | Canine Aβ42 |
Target/Biomarker | Canine Aβ42 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Canine Aβ42 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ42 level test of animal Dog/Canine with Alzheimer Disease(AD). |
Tag | His | Reconized/Reactive Specics | Canine Aβ42 |
Product description | Recombinant Canine Aβ42 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-AB42-Ab01,GMP-CAN-AB42-Ab02 |
Target/Biomarker | Canine Aβ42 |
Product Name | Anti-Canine Aβ42 mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Canine Aβ42 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ42 antibodies in Canine Aβ42 level test of animal Dog/Canine with Alzheimer Disease(AD). |
Product description | Anti-Canine Aβ42 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ42 antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-CAN-AB42-Ab03,GMP-CAN-AB42-Ab04 |
Target/Biomarker | Canine Aβ42 |
Product Name | Anti-Canine Aβ42 human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Canine Aβ42 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Canine Aβ42 antibodies in Canine Aβ42 level test of animal Dog/Canine with Alzheimer Disease(AD). |
Product description | Anti-Canine Aβ42 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Measuring Canine Aβ42 levels is paramount in veterinary medicine and neuroscience. Aβ42 has emerged as a critical biomarker due to its direct involvement in the pathogenesis of neurodegenerative diseases in dogs.
Elevated Aβ42 levels have been correlated with the severity of cognitive dysfunction in dogs. By quantifying Aβ42 in cerebrospinal fluid or brain tissue, veterinarians and researchers can gauge the extent of amyloid plaque formation and the associated neurotoxicity. This not only aids in early diagnosis but also offers an objective means of monitoring disease progression.
Beyond diagnosis, Aβ42 measurements play a pivotal role in preclinical research and drug development. They provide a quantifiable endpoint for evaluating the effectiveness of potential therapeutic interventions. Whether it's the development of disease-modifying drugs or strategies to enhance cognitive function in dogs, Aβ42 serves as a crucial indicator of treatment efficacy.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.